Wayrilz Tablet, Film Coated
Product Images NDC 58468-0251

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Wayrilz (NDC 58468-0251). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genzyme Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (95ffd367 9b0c 4f75 8487 5d8f3c0a5ad0 01)

Chemical Structure (95ffd367 9b0c 4f75 8487 5d8f3c0a5ad0 01)
Chemical structure diagram of rilzabrutinib, the active ingredient in WAYRILZ 400 mg film-coated tablets, showing the molecular arrangement of atoms and bonds in the compound.*
FDA Label Image

Principal Display Panel (60 Tablet Carton)

Principal Display Panel (60 Tablet Carton)
WAYRILZ 400 mg (rilzabrutinib) film-coated tablets packaging label. The label shows the product name, strength, and dosage form with a quantity of 60 tablets. It includes storage instructions, a warning to keep out of reach of children, barcode, manufacturer information (Genzyme Corporation, a Sanofi company), and NDC 58468-0251-6. The packaging states it is for prescription use only and provides a website for more information.*
FDA Label Image

Principal Display Panel (28 Tablet Blister Pack)

Principal Display Panel (28 Tablet Blister Pack)
WAYRILZ (rilzabrutinib) tablets 400 mg per tablet packaging label displays the product name, dosage strength, and tablet count of 28 per blister pack. The label provides opening instructions with a press and pull mechanism illustration. The labeler is Sanofi, and the packaging includes a barcode and storage warnings.*
FDA Label Image

Principal Display Panel (56 Tablet Blister Pack Carton)

Principal Display Panel (56 Tablet Blister Pack Carton)
WAYRILZ (rilzabrutinib) 400 mg film-coated tablets packaging label showing ingestion route as oral. The carton states it contains a total of 56 tablets in two blister packs of 28 tablets each. The labeler is Genzyme Corporation (Sanofi). The product NDC displayed is 58468-0251.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.